SCHEMBL9225828

SCHEMBL9225828

CN1CCCC(OS(=O)(=O)CCP(=O)(O)O)C1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.43
S1PR1 P21453 3/20 0.36
S1PR3 Q99500 3/20 0.36
S1PR5 Q9H228 3/20 0.36
HTT P42858 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CYP2D6 P10635 1/20 0.35
POLB P06746 1/20 0.35
S1PR4 O95977 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28725576 0.79 SMN1; SMN2 (0.47) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL8712186 0.74 SMN1; SMN2 (0.42) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL23175194 0.72 SMN1; SMN2 (0.46) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL3749371 0.72 SMN1; SMN2 (0.46) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL18379267 0.71 SMN1; SMN2 (0.49) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL14565210 0.71 SMN1; SMN2 (0.49) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL27567594 0.67 CHRM2 (0.48) SMN1; SMN2HTTL3MBTL1CYP2D6
SCHEMBL8712184 0.63 METAP1 (0.33) SMN1; SMN2S1PR1S1PR3S1PR5CYP2D6
SCHEMBL689750 0.62 SMN1; SMN2 (0.63) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL6206557 0.62 SMN1; SMN2 (0.63) SMN1; SMN2HTTL3MBTL1CYP2D6POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0642518-A1 PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMACEUTICALS (US) 1995-03-15 EP disclosed
WO-1993024495-A1 PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 1993-12-09 WO disclosed